These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30840220)

  • 1. Lacosamide in patients with intellectual disability and refractory epilepsy.
    Kleist A; Kerling F; Hamer H; Winterholler M
    Acta Neurol Belg; 2019 Sep; 119(3):423-430. PubMed ID: 30840220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural changes in patients with intellectual disability treated with brivaracetam.
    Andres E; Kerling F; Hamer H; Winterholler M
    Acta Neurol Scand; 2018 Sep; 138(3):195-202. PubMed ID: 29658982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S; Lutz MT; Mayer T
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
    Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
    Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide for SCN2A-related intractable neonatal and infantile seizures.
    Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H
    Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
    McGinnis E; Kessler SK
    Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
    Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
    Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural changes in patients with intellectual disability treated with perampanel.
    Andres E; Kerling F; Hamer H; Kasper B; Winterholler M
    Acta Neurol Scand; 2017 Dec; 136(6):645-653. PubMed ID: 28568478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of zonisamide in adult patients with intellectual disability.
    Eck K; Rauch C; Kerling F; Hamer H; Winterholler M
    Acta Neurol Scand; 2021 Sep; 144(3):275-282. PubMed ID: 33914900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
    Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
    Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.
    Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C
    Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from traditional sodium channel blockers to lacosamide in patients with epilepsy.
    Kim DW; Kim HK; Bae EK
    Seizure; 2019 Feb; 65():172-175. PubMed ID: 30721874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
    Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
    Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.